Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 341 across all filing types
Latest filing 2023-11-16 Regulatory Filings
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
주요사항보고서(영업정지)
Regulatory Filings Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding the suspension of business operations (영업정지). This is a specific regulatory disclosure required by the exchange for material corporate events. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-11-16 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the 3rd quarter of 2023, filed by Inbiogen Co., Ltd. to the Financial Supervisory Service and Korea Exchange. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which fits the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose their shareholdings and changes therein, which corresponds to the 'Director's Dealing' (DIRS) category in the provided classification schema.
2023-10-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by insiders or major shareholders, which falls under the 'Director's Dealing' (DIRS) category in the provided taxonomy, as it tracks insider/major shareholder transactions and holdings.
2023-10-10 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (Inbiogen) regarding the cancellation of a previously announced convertible bond issuance. This falls under capital structure changes and financing updates. Since it specifically details the cancellation of a financing instrument (convertible bond), it is classified as a Capital/Financing Update.
2023-09-25 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Inbiogen. It details changes in share ownership for major shareholders due to capital reduction. While it involves directors/major shareholders, it is a formal regulatory disclosure of shareholding changes rather than a personal 'Director's Dealing' (DIRS) report, and it is not a major shareholding notification (MRQ) in the sense of crossing a threshold for a new investor, but rather a mandatory disclosure of ownership structure changes. Given the specific nature of reporting major shareholder changes to the regulator, it fits best under 'Regulatory Filings' (RNS) as a standard corporate disclosure.
2023-09-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.